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Abstract 44 
The quality of reporting of practice guidelines is often poor and there is no widely accepted guidance 45 
or standards for the reporting of practice guidelines in healthcare. An international working group 46 
(the RIGHT working group) was therefore established to address this gap. The group followed an 47 
existing framework for developing health research reporting guidelines and the EQUATOR 48 
(Enhancing the QUAlity and Transparency Of health Research) Network approach.  49 
 50 
We developed a checklist and an explanation and elaboration document. The RIGHT checklist 51 
includes 22 items that we consider essential for good reporting of practice guidelines. These items 52 
encompass basic information (items 1-4), background (items 5-9), evidence (items 10-12), 53 
recommendations (items 13-15), review and quality assurance (items 16-17), funding and 54 
declaration and management of interests (items 18-19), and other information (items 20-22). The 55 
RIGHT checklist can assist developers when reporting their guidelines, support journal editors and 56 
peer reviewers when considering guideline reports, and help healthcare practitioners understand and 57 
implement a guideline.  58 
 59 
Primary Funding Source: National Natural Science Foundation of China, Grant No. 81503459 60 
  61 
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Introduction 62 
Clear, explicit and transparent practice guidelines enable healthcare practitioners, health 63 
administrators, program managers, and the public to understand and implement recommendations 64 
that may positively impact patients and populations (1). However, the quality of reporting of practice 65 
guidelines appears to be low (2) and current tools to address this are either outdated, have a narrow 66 
focus, or combine reporting and quality assessment in a single instrument. The Conference on 67 
Guideline Standardization (COGS) published a checklist for reporting of clinical practice guidelines 68 
(last updated in 2003) which focuses mainly on clinical medicine, and thus it may not be directly 69 
applicable to public health or to other types of guidelines (3).  The AGREE instrument was 70 
developed for both quality assessment and reporting, although it is widely regarded as an evaluation 71 
tool (6,7). Multi-function tools may not be optimal as it is important to distinguish between tools 72 
that address reporting and those that assess methodological quality as they differ in purpose, 73 
structure and content (8). Recently the AGREE Next Steps Consortium published the AGREE 74 
Reporting Checklist based on the AGREE instrument (4,5), however it is limited to items derived 75 
from the original tool, was developed by a small group of researchers and does not provide detailed 76 
explanation or guidance as to how to use the tool.   77 
 78 
Development of the RIGHT Checklist 79 
A multidisciplinary international team that included policy makers, methodologists, epidemiologists, 80 
clinicians, editors and consumer representatives from 12 countries across Asia, Africa, Europe, 81 
Oceania and North America was established in 2013. It aimed to develop a tool focusing on the 82 
essential items for reporting of guidelines—RIGHT (Reporting Items for Practice Guidelines in 83 
HealThcare). Development of the RIGHT checklist followed the framework for developing health 84 
research reporting guidelines (9). We registered the project in the EQUATOR (Enhancing the 85 
QUAlity and Transparency Of health Research) library (10). We established two groups: the RIGHT 86 
development group and the Delphi panelists group. The RIGHT development group drafted the 87 
project proposal, generated suggested items, recruited Delphi panelists, designed the questionnaires 88 
for the Delphi survey, and drafted the final report. The Delphi panelists group reviewed the proposal, 89 
participated in three rounds of Delphi surveys, came to consensus on the items included in the final 90 
checklist, and reviewed the final manuscript. 91 
 92 
The RIGHT development group implemented a four-step approach to generate potential items for 93 
the checklist. First, the group reviewed ten representative reporting guidelines highlighted in the 94 
EQUATOR library to determine how they generated potential items (11). The ten documents 95 
encompassed a wide variety of reporting tools, including for randomized controlled trials, diagnostic 96 
studies, observational studies, animal research, economic evaluation and systematic reviews. One 97 
tool generated items based on a systematic review (12) while the others used surveys, group 98 
meetings, literature reviews, or combined approaches (13-21). Second, we conducted a 99 
comprehensive search of handbooks and other documents to identify standards or tools for guideline 100 
reporting (see Appendix 1). Third, two sub-groups from the RIGHT development group, each 101 
composed of two experienced investigators, independently extracted potential checklist items from 102 
all documents identified in the first two steps. Last, the RIGHT development group held a face-to-103 
face meeting to aggregate all potential items and remove duplicates. After further discussion, 48 104 
items were included in the initial list of potential items. Readers can obtain the search results and 105 
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initial list of items from the RIGHT website (22).  106 
 107 
For the Delphi method, we recruited 17 individuals with experience in the development of practice 108 
guidelines or reporting guidelines. These individuals encompassed a broad range of disciplines as 109 
well as diverse geographic representation. The Delphi technique followed the recommendations 110 
proposed by Murphy and Sinha (23, 24) and included three rounds of email-based surveys. Panelists 111 
rated each item on a scale of 1 (not important) to 5 (very important), suggested new items, and 112 
provided comments that were circulated in subsequent rounds. All panelists were asked to disclose 113 
any conflicts of interest before beginning the Delphi survey. The response rate was 100% for all 114 
three rounds of the Delphi process.  115 
 116 
This study was funded by National Natural Science Foundation of China and the funder had no role 117 
in study design, data collection and analysis, decision to publish, or preparation of the manuscript. 118 
 119 
RIGHT Checklist 120 
The RIGHT checklist consists of 22 items that we consider essential for good reporting of practice 121 
guidelines (Table). These items encompass the following domains: basic information (item 1-4), 122 
background (items 5-9), evidence (items 10–12), recommendations (items 13–15), review and 123 
quality assurance (items 16–17), funding, declaration and management of interests (items 18–19), 124 
and other information (items 20-22). 125 
 126 
 127 
Discussion 128 
 129 
The RIGHT checklist can assist guideline developers when reporting their guidelines, support 130 
journal editors and peer reviewers when considering guideline reports, and help healthcare 131 
practitioners understand and implement a guideline. The checklist is useful for clinical practice 132 
guidelines as well as guidelines in public health and other healthcare fields since users and 133 
evaluators need a clear, explicit description of the processes and procedures used to develop a 134 
guideline, and access to the evidence used to formulate each recommendation. 135 
 136 
The RIGHT checklist does not prescribe a specific format for the reporting of guidelines. Rather, 137 
each checklist item should be clearly presented and in sufficient detail somewhere in the guideline.  138 
Order and format for each item depend on the developers’ preferences, style of the publication, and 139 
most importantly, the end-users' needs. We recommend against deriving a score from the RIGHT 140 
Checklist: the items may not be equally weighted and scores have been demonstrated to be 141 
problematic in research synthesis (25, 26). 142 
 143 
We emphasize that the RIGHT checklist was not developed as a tool for assessing the quality of 144 
published practice guidelines; such instruments exist elsewhere including AGREE (27) and others 145 
(28). Rather, RIGHT is intended to complement these existing tools.  RIGHT was also not 146 
developed as guidance for developing guidelines. Many handbooks exist for this purpose, along 147 
with the GIN-McMaster Guideline development checklist - a practical tool for guideline 148 
development supported by learning resources (29). Readers should carefully select a tool according 149 
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to their specific needs.  150 
 151 
The RIGHT checklist differs from the new AGREE reporting checklist (5) in several important ways. 152 
First, the structure of the AGREE reporting checklist follows the domains of AGREE II: scope and 153 
purpose, stakeholder involvement, rigour of development, clarity of presentation, applicability, and 154 
editorial independence. In contrast, the RIGHT checklist emulates the approach used by other 155 
reporting guidance statements such as CONSORT(15) and PRISMA(13) , ordering items as the 156 
developer and reader would encounter them.  Thus RIGHT starts with the title, then the executive 157 
summary, for example. Second, RIGHT includes important items that should be reported in a 158 
guideline that were not included in the AGREE reporting checklist:  quality assurance, access, 159 
suggestions for further research, and limitation of the guideline. RIGHT highlights the importance 160 
of reporting PICO questions and quality of the body of evidence, and includes seven sub-items on 161 
the formulation of recommendations from evidence. Finally, the RIGHT explanation and 162 
elaboration statement (appendix 2) provides detailed information and examples, which are not part 163 
of the AGREE reporting checklist.   164 
 165 
Implementation 166 
Endorsement and implementation of reporting guidelines may help reduce wasteful research and 167 
increase the potential impact of research on health (30). We plan to use a number of approaches to 168 
promote implementation of the RIGHT checklist: ask authors of international guideline handbooks 169 
to add the RIGHT checklist into new versions of their handbooks; contact the editors of the core 170 
clinical journals in MEDLINE (https://www.nlm.nih.gov/bsd/aim.html) to elicit their support and 171 
encourage them to endorse the RIGHT checklist; and inform guideline developers at international 172 
and national agencies, as well as professional societies about RIGHT. 173 
 174 
Strengths and limitations 175 
We followed an explicit, transparent and documented process for developing the RIGHT checklist 176 
and we provide an accompanying explanation and elaboration statement (See online appendix). 177 
Individuals from key international organizations and institutions that focus on development and 178 
implementation of guidelines contributed to this work, including the EQUATOR network, 179 
Guidelines International Network, the GRADE Working Group, the AGREE Collaboration and the 180 
Cochrane Collaboration. The draft checklist and explanation and elaboration statement underwent 181 
extensive peer review by experts in guideline development with a variety of perspectives. It is 182 
possible that we missed important items when we developed our initial list of items, however we 183 
made every effort to minimize this possibility by examining a large number of guidance documents 184 
and manuals produced by guideline developers and by consulting a broad range of experts in this 185 
field.   186 
 187 
Future development and research 188 
The RIGHT checklist is currently available in English, German, Croatian, Japanese, Korean, 189 
Simplified and Traditional Chinese, and we encourage groups to undertake additional translations. 190 
We plan to develop RIGHT extensions, including RIGHT-P (for Guideline Proposals), RIGHT-COI 191 
(for Conflicts of Interest), and RIGHT-A (for Acupuncture). We ask those who aim to develop 192 
related standards or perform translations to contact the corresponding author of this paper to 193 
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coordinate efforts and to avoid duplication. 194 
 195 
As for any other reporting standard, the RIGHT checklist is an evolving document that needs 196 
continual assessment, improvement, and updating. We will revise the checklist in the future, taking 197 
into account user feedback, results of formal and informal evaluations, and new studies on guideline 198 
reporting methods. We encourage users to submit their comments via the RIGHT website. 199 
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